PMID: 225007Sep 1, 1979Paper

Cell kinetic analyses of human malignant brain tumors (gliomas)

Cancer
T Hoshino, C B Wilson

Abstract

Administration of 3H-thymidine, either with or without mitostatic agents, to 24 patients with various gliomas revealed 1) in viable areas a labeling index (LI) for glioblastomas equal to 5-15%, 2) an LI of 1% or less in well-differentiated gliomas, and 3) the LI of anaplastic astrocytomas was intermediate and reflected the extent of anaplasia. Growth fraction was 0.14-0.44 in malignant gliomas (average 0.31 +/- 0.10), and cell cycle time obtained by means of stathmokinetic analysis was 75.6 +/- 45.7 hr. With few exceptions, the patients whose tumors showed an LI of 5% or more died within 1 year after the onset of disease, and no patients whose tumors at biopsy had an LI of over 5% survived more than 6 months. In contrast, there was a far better prognosis for patients whose tumors demonstrated an LI of less than 1%.

References

Jul 1, 1978·Journal of Neurosurgery·T HoshinoJ W Gray
Jan 1, 1977·Bulletin of Mathematical Biology·L A LiottaJ Kleinerman
Feb 1, 1975·Journal of Neurosurgery·T Hoshino, C B Wilson
Dec 1, 1975·Archives of Neurology·V A LevinH D Landahl
Mar 1, 1967·The Journal of Comparative Neurology·O R Hommes, C P Leblond
Nov 1, 1967·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M F Rajewsky
Jul 1, 1972·Journal of Neurosurgery·T HoshinoD Fewer
Jun 1, 1974·British Journal of Cancer·R S Camplejohn, W Aherne
Aug 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R S CamplejohnW Aherne
Mar 14, 1969·Science·M A Van DillaJ R Coulter
Nov 1, 1967·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O H Iversen
Apr 1, 1940·Journal of Neurology and Psychiatry·H J Scherer

Citations

Jan 1, 1984·Cancer Metastasis Reviews·O D LaerumL de Ridder
Jul 1, 1989·Journal of Neuro-oncology·T HoshinoC B Wilson
Jan 1, 1989·Journal of Cancer Research and Clinical Oncology·M DeckertW Wechsler
Jan 1, 1986·Acta Neuropathologica·K HirakawaJ Handa
Jan 1, 1987·Acta Neuropathologica·F GiangasperoH Stein
Jul 1, 1993·Journal of Neuro-oncology·T NishizakiK Sasaki
Oct 1, 1995·Journal of Neuro-oncology·Y YoshiiT Nose
Jan 1, 1991·Virchows Archiv. A, Pathological Anatomy and Histopathology·A AllegranzaM Barbareschi
Sep 1, 1988·Journal of Neuro-oncology·Y YoshiiK Sugiyama
Jul 1, 1995·Leukemia Research·H D Preisler
Jul 1, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·B JeremicJ Aleksandrovic
Apr 4, 2000·Bio Systems·A R KansalT S Deisboeck
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ivana BozicMartin A Nowak
Jun 1, 1995·Cell Proliferation·H D Preisler, P Venugopal
Apr 1, 1993·Neuropathology and Applied Neurobiology·T ReveszD G Thomas
Jun 26, 2003·Neurosurgery·Makoto NakamuraMadjid Samii
Apr 1, 1986·Journal of Neurosurgery·T NagashimaS J DeArmond

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.